These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 7493000)
1. Effects of 6-(10-hydroxydecyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinone (idebenone) and related benzoquinones on porcine pancreas phospholipase A2 activity. Amano T; Terao S; Imada I Biol Pharm Bull; 1995 May; 18(5):779-81. PubMed ID: 7493000 [TBL] [Abstract][Full Text] [Related]
2. The effect of coenzyme Q10 on the action of phospholipase. Sugiyama S; Hattori M; Nagai S; Takamura T; Ozawa T Arzneimittelforschung; 1985; 35(1):23-5. PubMed ID: 4039149 [TBL] [Abstract][Full Text] [Related]
4. Antioxidant properties of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone (idebenone). Mordente A; Martorana GE; Minotti G; Giardina B Chem Res Toxicol; 1998 Jan; 11(1):54-63. PubMed ID: 9477226 [TBL] [Abstract][Full Text] [Related]
5. [Synthesis and biochemical actions of idebenone and related compounds. Ubiquinone and related compounds, XL]. Morimoto H Naturwissenschaften; 1989 May; 76(5):200-5. PubMed ID: 2664530 [TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of conformationally restricted phospholipids as phospholipase A2 inhibitors. Magolda RL; Galbraith W J Cell Biochem; 1989 Jul; 40(3):371-86. PubMed ID: 2777909 [TBL] [Abstract][Full Text] [Related]
7. Phospholipase A2 domain formation in hydrolyzed asymmetric phospholipid monolayers at the air/water interface. Maloney KM; Grandbois M; Grainger DW; Salesse C; Lewis KA; Roberts MF Biochim Biophys Acta; 1995 May; 1235(2):395-405. PubMed ID: 7756350 [TBL] [Abstract][Full Text] [Related]
8. Interfacial catalysis by phospholipase A2: evaluation of the interfacial rate constants by steady-state isotope effect studies. Ghomashchi F; O'Hare T; Clary D; Gelb MH Biochemistry; 1991 Jul; 30(29):7298-305. PubMed ID: 1854738 [TBL] [Abstract][Full Text] [Related]
9. Protective effects of idebenone on vascular endothelial cells against toxicity induced by oxidatively modified low density lipoprotein. Naito M; Hayashi T; Yamada K; Asai K; Yoshimine N; Iguchi A Artery; 1993; 20(6):314-23. PubMed ID: 8010887 [TBL] [Abstract][Full Text] [Related]
10. [Inhibition of phospholipid hydrolysis by phospholipase A2 in microsomal and mitochondrial membranes subjected to lipid peroxidation]. Balevska PS; Kassabova EM; Rusanov EM; Kagan VE Biull Eksp Biol Med; 1985 Feb; 99(2):161-4. PubMed ID: 3971034 [TBL] [Abstract][Full Text] [Related]
11. Binding of quinacrine to acidic phospholipids and pancreatic phospholipase A2. Effects on the catalytic activity of the enzyme. Mustonen P; Lehtonen JY; Kinnunen PK Biochemistry; 1998 Sep; 37(35):12051-7. PubMed ID: 9724516 [TBL] [Abstract][Full Text] [Related]
12. Rat platelet phospholipase A2. Kinetic characterization using the monomolecular film technique. Ransac S; Aarsman AJ; van den Bosch H; Gancet C; de Haas GH; Verger R Eur J Biochem; 1992 Mar; 204(2):793-7. PubMed ID: 1541292 [TBL] [Abstract][Full Text] [Related]
13. The interaction of Q analogs, particularly hydroxydecyl benzoquinone (idebenone), with the respiratory complexes of heart mitochondria. Esposti MD; Ngo A; Ghelli A; Benelli B; Carelli V; McLennan H; Linnane AW Arch Biochem Biophys; 1996 Jun; 330(2):395-400. PubMed ID: 8660670 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the catalytic properties of phospholipase A2 from pancreas and venom using a continuous fluorescence displacement assay. Kinkaid A; Wilton DC Biochem J; 1991 Sep; 278 ( Pt 3)(Pt 3):843-8. PubMed ID: 1898370 [TBL] [Abstract][Full Text] [Related]
15. Interfacial catalysis by phospholipase A2: monomeric enzyme is fully catalytically active at the bilayer interface. Jain MK; Ranadive G; Yu BZ; Verheij HM Biochemistry; 1991 Jul; 30(29):7330-40. PubMed ID: 1854741 [TBL] [Abstract][Full Text] [Related]
16. Fatty acid and phospholipid selectivity of different phospholipase A2 enzymes studied by using a mammalian membrane as substrate. Diez E; Chilton FH; Stroup G; Mayer RJ; Winkler JD; Fonteh AN Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):721-6. PubMed ID: 8053897 [TBL] [Abstract][Full Text] [Related]
17. Are phospholipid-binding proteins in vivo phospholipase inhibitors? Poensgen J Klin Wochenschr; 1989 Feb; 67(3):163-5. PubMed ID: 2494377 [TBL] [Abstract][Full Text] [Related]
18. Activation of phospholipase A2 by amyloid beta-peptides in vitro. Lehtonen JY; Holopainen JM; Kinnunen PK Biochemistry; 1996 Jul; 35(29):9407-14. PubMed ID: 8755719 [TBL] [Abstract][Full Text] [Related]
19. Modulation of phospholipase A2 activity by the tumour promoters phorbol esters and teleocidin. Nam KY; Morino A; Kimura S; Fujiki H; Imanishi Y Biochem J; 1990 May; 268(1):169-73. PubMed ID: 2344355 [TBL] [Abstract][Full Text] [Related]
20. Hydrolysis of DMPC or DPPC by pancreatic phospholipase A2 is slowed down when (perfluoroalkyl) alkanes are incorporated into the liposomal membrane. Privitera N; Naon R; Riess JG Biochim Biophys Acta; 1995 Jan; 1254(1):1-6. PubMed ID: 7811738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]